Project 2: Innate Immune Pathways in Food-induced Anaphylaxis
项目 2:食物引起的过敏反应中的先天免疫途径
基本信息
- 批准号:10635815
- 负责人:
- 金额:$ 5.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-06 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllergen ImmunotherapyAllergensAllergicAllergic ReactionAllergy to peanutsAnaphylaxisAntigen-Antibody ComplexAntigensArachis hypogaeaBasophilsBindingBloodBlood PlateletsBlood specimenCD34 geneCellsChildCirculationClinicalCoculture TechniquesComplexDataDoseDouble-Blind MethodEnteroendocrine CellEnzyme-Linked Immunosorbent AssayExposure toFCGR3B geneFlow CytometryFoodFood HypersensitivityG-Protein-Coupled ReceptorsGPR35 geneGastrointestinal tract structureGene Expression ProfilingHistamineHourHumanHydroxyindoleacetic AcidIgEImmuneImmunoglobulin GImmunotherapyIn VitroIndividualInnate Immune ResponseInterruptionInterventionIntestinesLigandsMacrophageMass Spectrum AnalysisMeasuresMediatingMediatorMusNatural ImmunityNeutrophil ActivationNeutrophil InfiltrationOralPathogenesisPathway interactionsPatientsPeripheralPhenotypePlacebo ControlPlacebosPlasmaPlatelet Activating FactorPreventionProteinsReactionRoleSerotoninSerotonin ProductionSerumSeveritiesSourceTestingWhole Bloodabsorptioncohortcrosslinkfood challengegenetic signaturehigh dimensionalityimmune activationin vivoinnate immune mechanismsinnate immune pathwaysmast cellmouse modelneutrophilnovelperipheral bloodpreventprogramsreceptorresponsetranscriptome sequencing
项目摘要
SUMMARY – Project 2
Food allergy is mediated by IgE triggering of mast cells and basophils. We found that peanut-specific IgE and
basophil activation test could distinguish allergic from sensitized individuals, but had no utility in predicting
reaction severity during double blind placebo controlled food challenges (DBPCFC). Distinguishing mild from
potentially severe reactions would be of major clinical benefit. Transcriptional profiling identified a neutrophil
signature that was associated not only with reactions to peanut, but also with severity of reactions. Flow
cytometry profiling identified a significant increase in circulating neutrophils post-challenge, and preliminary
data shows a change in neutrophil phenotype consistent with activation. Although neutrophils have been
shown to be activated by IgG-allergen complexes, it is unlikely that there would be significant immune complex
formation due to the low dose of peanut exposure. Neutrophils have been shown to be responsive to serotonin
metabolites, and in preliminary data we demonstrate that activation of whole blood with peanut induces
serotonin release. Human mast cells (and potentially basophils) produce low levels of serotonin, but platelets
are a major source of serotonin in the circulation and can release it upon activation. We have previously shown
that platelets form complexes with basophils in blood from peanut allergic individuals upon exposure to peanut.
We hypothesize that basophil-platelet complexes are responsible for the release of serotonin, which then
activates neutrophils in the context of food allergy. We will test this hypothesis with three specific aims. The
first aim will use spectral flow cytometry and RNA sequencing to examine neutrophil and other innate immune
activation during DBPCFC. The second aim will examine the release of serotonin and serotonin metabolites
during reactions and test the role of serotonin and metabolites in neutrophil activation. The third aim will
examine the contribution of basophil platelet complexes to the production of serotonin in response to peanut
exposure. Successful completion of these aims will reveal novel innate immune mechanisms of severe
reactions to peanut, leading the way to new interventions for the prevention of severe peanut allergy.
摘要-项目2
食物过敏是由IgE触发肥大细胞和嗜碱性粒细胞介导的。我们发现花生特异性IgE和
嗜碱性粒细胞活化试验可区分过敏和致敏个体,但对预测过敏和致敏个体的预后无意义。
双盲安慰剂对照食物激发(DBPCFC)期间的反应严重程度。区分轻度和
潜在的严重反应将具有重大的临床益处。转录谱鉴定出一种中性粒细胞
这不仅与对花生的反应有关,而且与反应的严重程度有关。流
细胞计数分析确定了攻击后循环中性粒细胞的显著增加,并且初步
数据显示中性粒细胞表型的变化与活化一致。虽然中性粒细胞已经
虽然显示被IgG-变应原复合物激活,但不太可能存在显著的免疫复合物,
由于低剂量的花生暴露而形成。中性粒细胞对血清素有反应
代谢物,并在初步数据中,我们证明,活化全血与花生诱导,
血清素释放人类肥大细胞(以及潜在的嗜碱性粒细胞)产生低水平的血清素,但血小板
是血液循环中血清素的主要来源,激活后可释放血清素。我们先前已经表明
花生过敏个体暴露于花生后,血小板与血液中的嗜碱性粒细胞形成复合物。
我们假设嗜碱性粒细胞-血小板复合物负责释放血清素,
在食物过敏的情况下激活中性粒细胞。我们将以三个具体目标来检验这一假设。的
第一个目标将使用光谱流式细胞术和RNA测序来检查中性粒细胞和其他先天免疫细胞,
在DBPCFC期间激活。第二个目标将检查血清素和血清素代谢物的释放
在反应过程中,并测试血清素和代谢物在中性粒细胞活化中的作用。第三个目标将
研究嗜碱性粒细胞血小板复合物对花生产生血清素的作用
exposure.这些目标的成功实现将揭示重症肌无力的新的先天免疫机制。
研究人员正在研究对花生的过敏反应,为预防严重花生过敏的新干预措施开辟道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Supinda Bunyavanich其他文献
Supinda Bunyavanich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Supinda Bunyavanich', 18)}}的其他基金
Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center
早期特应性系统生物学(SUNBEAM)分析和生物信息学中心
- 批准号:
10573523 - 财政年份:2022
- 资助金额:
$ 5.16万 - 项目类别:
Threshold, Severity, and Immunotherapy of Peanut Allergy
花生过敏的阈值、严重程度和免疫治疗
- 批准号:
10635811 - 财政年份:2018
- 资助金额:
$ 5.16万 - 项目类别:
Biomarkers and causal key drivers of phenotypic heterogeneity in peanut allergy
花生过敏表型异质性的生物标志物和关键驱动因素
- 批准号:
10415894 - 财政年份:2018
- 资助金额:
$ 5.16万 - 项目类别:
Project 1: Integrated Transcriptomics of Severity, Immunotherapy, and endotypes in Peanut Allergy
项目 1:花生过敏严重程度、免疫治疗和内型的综合转录组学
- 批准号:
10635814 - 财政年份:2018
- 资助金额:
$ 5.16万 - 项目类别:
相似海外基金
Immunological profiling of multi-food allergen immunotherapy assessing humoral and cellular activation profiles
多种食物过敏原免疫疗法的免疫学分析,评估体液和细胞激活情况
- 批准号:
449815 - 财政年份:2020
- 资助金额:
$ 5.16万 - 项目类别:
Studentship Programs
Elucidation of mechanisms for induction of regulatory T cells by IgG1 that increase in allergen immunotherapy
阐明过敏原免疫治疗中增加的 IgG1 诱导调节性 T 细胞的机制
- 批准号:
19K16385 - 财政年份:2019
- 资助金额:
$ 5.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The combination of allergen immunotherapy with anti-IL-4 receptor-alpha antibody (dupilumab) for induction of human allergen-specific tolerance
过敏原免疫疗法与抗 IL-4 受体-α 抗体(dupilumab)相结合,用于诱导人类过敏原特异性耐受
- 批准号:
MR/T00164X/1 - 财政年份:2019
- 资助金额:
$ 5.16万 - 项目类别:
Fellowship
Identifying the mechanism of allergen immunotherapy using single cell and bulk gene expression information.
使用单细胞和大量基因表达信息识别过敏原免疫治疗的机制。
- 批准号:
19H03696 - 财政年份:2019
- 资助金额:
$ 5.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Challenge for treatment of dog allergy by allergen immunotherapy using hypoallergenic vaccine
使用低过敏性疫苗进行过敏原免疫疗法治疗狗过敏的挑战
- 批准号:
17K19329 - 财政年份:2017
- 资助金额:
$ 5.16万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of a Dissolving Film for Allergen Immunotherapy in Children
开发用于儿童过敏原免疫治疗的溶解膜
- 批准号:
8676849 - 财政年份:2013
- 资助金额:
$ 5.16万 - 项目类别:
Development of a Dissolving Film for Allergen Immunotherapy in Children
开发用于儿童过敏原免疫治疗的溶解膜
- 批准号:
8510886 - 财政年份:2013
- 资助金额:
$ 5.16万 - 项目类别:
Proof of concept study of combined allergen immunotherapy and antibiotics for the treatment of chronic atopic dermatitis
过敏原免疫疗法和抗生素联合治疗慢性特应性皮炎的概念验证研究
- 批准号:
G0701693/1 - 财政年份:2009
- 资助金额:
$ 5.16万 - 项目类别:
Research Grant
ALLERGEN IMMUNOTHERAPY CO-ADMINISTERED WITH OMALIZUMAB, AN ANTI-IGE MAB
过敏原免疫疗法与 OMALIZUMAB(一种抗 IGE 单克隆抗体)联合使用
- 批准号:
7201329 - 财政年份:2005
- 资助金额:
$ 5.16万 - 项目类别:
Allergen Immunotherapy Co-Administered with Omalizumab
过敏原免疫疗法与奥马珠单抗联合给药
- 批准号:
7040810 - 财政年份:2004
- 资助金额:
$ 5.16万 - 项目类别:














{{item.name}}会员




